Mesenchymal Stem Cell Isolation Using Extracellular Matrix Coating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The low frequency and success rate of isolating mesenchymal stem cells (MSCs) from umbilical cord blood (UCB) using traditional methods, along with their poor adherence to plastic and difficulty in maintaining stem cell properties in long-term culture, limit their therapeutic and research applications.
Innovation Solution
Isolating MSCs by adherence to an extracellular matrix (ECM) formed by culturing human bone marrow cells, which enhances attachment, proliferation, and retention of stem cell properties, resulting in a significantly higher yield and ability to generate tissues from three embryonic germ layers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional plastic adhesion method is used, then the isolation procedure is simple, but the frequency of MSC isolation is extremely low
Solution Approach 1:
The patent introduces an extracellular matrix (ECM) as an intermediary substance between the plastic surface and the mesenchymal stem cells. The ECM, derived from bone marrow stromal cells, serves as a mediating layer that significantly enhances MSC attachment and isolation efficiency from umbilical cord blood, increasing the isolation frequency by at least 1000-fold compared to direct plastic adhesion.
2Reliability
If traditional plastic adhesion method is used, then the culture method is simple, but the ability to retain stem cell properties is poor
Solution Approach 1:
The patent applies preliminary action by pre-coating the culture dish with extracellular matrix (ECM) derived from bone marrow stromal cells before seeding the umbilical cord blood samples. This pre-prepared ECM layer creates a favorable microenvironment that enhances MSC attachment, proliferation, and retention of stem cell properties, allowing for long-term culture while maintaining cellular characteristics.
3Productivity
If ECM formed by bone marrow cells is used, then the attachment and proliferation of MSCs is enhanced, but the preparation of ECM adds process complexity
Solution Approach 1:
The ECM is prepared in advance by culturing bone marrow stromal cells to form a confluent monolayer, which is then processed and stored as a pre-formed extracellular matrix. This preliminary preparation allows the ECM to be readily available for coating culture dishes, significantly enhancing MSC attachment and proliferation without adding complexity to the actual isolation procedure, as the ECM preparation is completed beforehand.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method increases the frequency of MSC isolation from UCB by at least 1000-fold, allowing for the generation of differentiated tissues from umbilical cord-derived embryonic-like stem cells, facilitating research and potential clinical applications.
Implementation Method 1
Isolating MSCs by adherence to an extracellular matrix (ECM) formed by culturing human bone marrow cells, which enhances attachment, proliferation, and retention of stem cell properties
Data Source
Figure 1A~1D
Figure 2
Figure 3A~3D
AI summary
Human umbilical cord blood (UCB) contains mesenchymal stem cells (MSCs) that have higher multipotentiality than adult marrow-derived MSCs. However, it has been difficult to obtain these cells because the frequency of MSCs in UCB is extremely rare (0.4 - 30 out of 1 X 108 mononuclear cells). To date, the isolation of MSCs has depended upon their plastic-adhesion capacity. Some "true" MSCs could be missed because their ability to adhere to plastic may be poor. Previous studies demonstrated extracellular matrix (ECM) made by bone marrow cells enhanced MSC attachment and proliferation, and retained their stem cell properties. The present invention provides methods for isolating MSCs from umbilical cord blood by adherence to an ECM and uses for the isolated stem cells.